David J. Nutt

Death and Dependence: Current Controversies over the Selective Serotonin Reuptake Inhibitors
J Psychopharmacol 2003 17: 355-364. [Abstract] [PDF] [References]  

Thomas R. E. Barnes

The Barnes Akathisia Rating Scale–Revisited
J Psychopharmacol 2003 17: 365-370. [Abstract] [PDF] [References]  

Suzanne L. Verheyden, Rachel Maidment, and H. Valerie Curran

Quitting Ecstasy: An Investigation of Why People Stop Taking the Drug and Their Subsequent Mental Health
J Psychopharmacol 2003 17: 371-378. [Abstract] [PDF] [References]  

C. T. J. Lamers, J. G. Ramaekers, N. D. Muntjewerff, K. L. Sikkema, W. J. Riedel, N. Samyn, N. L. Read, and K. A. Brookhuis

Dissociable Effects of a Single Dose of Ecstasy (MDMA) on Psychomotor Skills and Attentional Performance
J Psychopharmacol 2003 17: 379-387. [Abstract] [PDF] [References]  

J. Rodgers, T. Buchanan, A. B. Scholey, T. M. Heffernan, J. Ling, and A. C. Parrott

Patterns of Drug Use and the Influence of Gender on Self-Reports of Memory Ability in Ecstasy Users: A Web-Based Study
J Psychopharmacol 2003 17: 389-396. [Abstract] [PDF] [References]  

Jonathan Chick, Philippe Lehert, and Frederic Landron

Does Acamprosate Improve Reduction of Drinking As Well As Aiding Abstinence?
J Psychopharmacol 2003 17: 397-402. [Abstract] [PDF] [References]  

C. W. Wright, M. Gott, B. Grayson, A. G. Smith, A. Sunter, J. C. Neill, and M. Hanna

Correlation of Hyperforin Content of Hypericum Perforatum(St John’s Wort) Extracts with Their Effects On Alcohol Drinking in C57Bl/6J Mice: A Preliminary Study
J Psychopharmacol 2003 17: 403-408. [Abstract] [PDF] [References]  

Koichi Isogawa, Jotaro Akiyoshi, Takashi Tsutsumi, Kensuke Kodama, Yukiko Horinouti, and Haruo Nagayama

Anxiogenic-Like Effect of Corticotropin-Releasing Factor Receptor 2 Antisense Oligonucleotides Infused into Rat Brain
J Psychopharmacol 2003 17: 409-413. [Abstract] [PDF] [References]  

Ameneh Rezayof, Mohammad-Reza Zarrindast, Hedayat Sahraei, and Ali Haeri-Rohani

Involvement of Dopamine Receptors of the Dorsal Hippocampus on the Acquisition and Expression of Morphine-Induced Place Preference in Rats
J Psychopharmacol 2003 17: 415-423. [Abstract] [PDF] [References]  

T. S. Ehmann, T. Kragelj, E. Higgs, S. W. Flynn, S. Altman, G. N. Smith, W. G. Honer, and G. W. Macewan

Outcome Measurement in Pharmacological Trials: Validity of the Routine Assessment of Patient Progress (RAPP)
J Psychopharmacol 2003 17: 425-429. [Abstract] [PDF] [References]  

Kelly A. Gendall, Peter R. Joyce, Roger T. Mulder, and Sue E. Luty

Thyroid Indices and Response to Fluoxetine and Nortriptyline in Major Depression
J Psychopharmacol 2003 17: 431-437. [Abstract] [PDF] [References]  

Maria C. Jockers-ScherüBl, Uta Matthies, Heidi Danker-Hopfe, Undine E. Lang, Richard Mahlberg, and Rainer Hellweg

Chronic Cannabis Abuse Raises Nerve Growth Factor Serum Concentrations in Drug-Naive Schizophrenic Patients
J Psychopharmacol 2003 17: 439-445. [Abstract] [PDF] [References]  

Lut Tamam and Nurgul Ozpoyraz

Discontinuation Symptoms Associated with Nefazodone
J Psychopharmacol 2003 17: 447-450. [Abstract] [PDF] [References]  

Lars Hansen

Fluoxetine Dose-Increment Related Akathisia in Depression: Implications for Clinical Care, Recognition and Management of Selective Serotonin Reuptake Inhibitor-Induced Akathisia
J Psychopharmacol 2003 17: 451-452. [Abstract] [PDF] [References]  

Sanjiv Gulati, Ashok N. Singh, and Sue E. Libretto

Successful Risperidone Rechallenge after Blepharospasm in a Patient with Schizophrenia: 24-Month Follow-Up
J Psychopharmacol 2003 17: 453-454. [Abstract] [PDF] [References]  

Anna Maria Meaney and Veronica O’Keane

Reduced Bone Mineral Density in Patients with Schizophrenia Receiving Prolactin Raising Anti-Psychotic Medication
J Psychopharmacol 2003 17: 455-458. [Abstract] [PDF] [References]  

Raphael M. Bonelli, Brigitte M. Mayr, Gerald Niederwieser, Franz Reisecker, and Hans-Peter Kapfhammer

Ziprasidone in Huntington’s Disease: The First Case Reports
J Psychopharmacol 2003 17: 459-460. [Abstract] [PDF] [References]  

Raphael M. Bonelli and Hans-Peter Kapfhammer

Why Minocycline is Helpful in Huntington’s Disease
J Psychopharmacol 2003 17: 461. [PDF] [References]  

Dora Kohen

Book Review
J Psychopharmacol 2003 17: 462. [PDF]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.